LONDON, UK: DeepMatter Group (AIM: DMTR), the international digital chemistry data company, has signed a licensing and collaboration agreement with Standigm Inc., a leading workflow artificial intelligence (AI) drug discovery company, based in South Korea with an increasing international footprint. The first stage of the agreement is expected to generate revenues of £233,000. The Group…